Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwaf527
Abstract: AIMS Lipoprotein(a) (Lp(a)) is a genetic causal risk factor for atherosclerotic cardiovascular disease (ASCVD), irrespective of ancestry. INTERASPIRE is an international cohort study of secondary prevention conducted in 14 countries from all 6 WHO regions.… read more here.
Keywords: perspectives testing; physician perspectives; cardiovascular disease; testing management ... See more keywords
Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008376
Abstract: Key Points • Many young breast cancer survivors are interested in CHIP testing, with preferences varying by risk communication and actionability.• Learning of CHIP and its associated risks may elicit significant anxiety, requiring provider awareness… read more here.
Keywords: perspectives testing; testing clonal; indeterminate potential; hematopoiesis indeterminate ... See more keywords